222 related articles for article (PubMed ID: 30642312)
1. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
[TBL] [Abstract][Full Text] [Related]
2. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
3. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
5. Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study.
Kolditz M; Tesch F; Mocke L; Höffken G; Ewig S; Schmitt J
Respir Med; 2016 Dec; 121():32-38. PubMed ID: 27888989
[TBL] [Abstract][Full Text] [Related]
6. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
7. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
8. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
9. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
McLaughlin JM; Johnson MH; Kagan SA; Baer SL
Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
Yu H; Rubin J; Dunning S; Li S; Sato R
J Am Geriatr Soc; 2012 Nov; 60(11):2137-43. PubMed ID: 23110409
[TBL] [Abstract][Full Text] [Related]
12. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
[TBL] [Abstract][Full Text] [Related]
13. Community acquired pneumonia and direct hospital cost.
Doruk S; Tertemiz KC; Kömüs N; Uçan ES; Kilinç O; Sevinç C
Tuberk Toraks; 2009; 57(1):48-55. PubMed ID: 19533437
[TBL] [Abstract][Full Text] [Related]
14. Population-based incidence and mortality of community-acquired pneumonia in Germany.
Theilacker C; Sprenger R; Leverkus F; Walker J; Häckl D; von Eiff C; Schiffner-Rohe J
PLoS One; 2021; 16(6):e0253118. PubMed ID: 34129632
[TBL] [Abstract][Full Text] [Related]
15. The cost of treating community-acquired pneumonia.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
[TBL] [Abstract][Full Text] [Related]
16. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
17. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.
Keitel K; Alcoba G; Lacroix L; Manzano S; Galetto-Lacour A; Gervaix A
Swiss Med Wkly; 2014; 144():w13925. PubMed ID: 24706389
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.
Ehlken B; Ihorst G; Lippert B; Rohwedder A; Petersen G; Schumacher M; Forster J;
Eur J Pediatr; 2005 Oct; 164(10):607-15. PubMed ID: 15965766
[TBL] [Abstract][Full Text] [Related]
19. Work-related and health care cost burden of community-acquired pneumonia in an employed population.
Kleinman NL; Yu H; Beren IA; Sato R
J Occup Environ Med; 2013 Oct; 55(10):1149-56. PubMed ID: 24064787
[TBL] [Abstract][Full Text] [Related]
20. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
